- Home
- FHTX vs MYPS Comparison
FHTX vs MYPS Comparison
Compare FHTX & MYPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FHTX
- MYPS
- Stock Information
- Founded
- FHTX 2015
- MYPS 2011
- Country
- FHTX United States
- MYPS United States
- Employees
- FHTX N/A
- MYPS N/A
- Industry
- FHTX Medicinal Chemicals and Botanical Products
- MYPS EDP Services
- Sector
- FHTX Health Care
- MYPS Technology
- Exchange
- FHTX Nasdaq
- MYPS Nasdaq
- Market Cap
- FHTX 237.4M
- MYPS 229.4M
- IPO Year
- FHTX 2020
- MYPS N/A
- Fundamental
- Price
- FHTX $4.40
- MYPS $1.87
- Analyst Decision
- FHTX Strong Buy
- MYPS Hold
- Analyst Count
- FHTX 5
- MYPS 5
- Target Price
- FHTX $13.80
- MYPS $3.17
- AVG Volume (30 Days)
- FHTX 170.9K
- MYPS 230.2K
- Earning Date
- FHTX 03-06-2025
- MYPS 03-10-2025
- Dividend Yield
- FHTX N/A
- MYPS N/A
- EPS Growth
- FHTX N/A
- MYPS N/A
- EPS
- FHTX N/A
- MYPS N/A
- Revenue
- FHTX $25,515,000.00
- MYPS $298,759,000.00
- Revenue This Year
- FHTX N/A
- MYPS N/A
- Revenue Next Year
- FHTX $7.37
- MYPS N/A
- P/E Ratio
- FHTX N/A
- MYPS N/A
- Revenue Growth
- FHTX N/A
- MYPS N/A
- 52 Week Low
- FHTX $2.70
- MYPS $1.20
- 52 Week High
- FHTX $10.25
- MYPS $3.04
- Technical
- Relative Strength Index (RSI)
- FHTX 33.35
- MYPS 50.93
- Support Level
- FHTX $4.13
- MYPS $1.66
- Resistance Level
- FHTX $4.52
- MYPS $1.87
- Average True Range (ATR)
- FHTX 0.34
- MYPS 0.10
- MACD
- FHTX 0.08
- MYPS -0.00
- Stochastic Oscillator
- FHTX 20.88
- MYPS 60.29
About FHTX Foghorn Therapeutics Inc.
Foghorn Therapeutics Inc is engaged in the discovery and development of a new class of medicines targeting genetically determined dependencies within the chromatin regulatory system. Its proprietary Gene Traffic Control platform gives an integrated, mechanistic understanding of how the various components of the chromatin regulatory system interact, allowing it to identify, validate, and potentially drug targets within the system. The company is developing FHD-286, a selective, allosteric ATPase inhibitor, and FHD-609, a protein degrader, to treat hematologic cancers and solid tumors.
About MYPS PLAYSTUDIOS Inc.
PLAYSTUDIOS Inc is engaged in gaming and related business. The Company develops and operates online and mobile social gaming applications (games or game), many of which incorporate a loyalty program offering real world rewards provided by a collection of awards partners. The Company's games are free-to-play and available via the Apple App Store, Google Play Store, Amazon Appstore, and Facebook (collectively, platforms or platform operators). The Company creates games based on its own original content as well as third-party licensed brands. The Company generates revenue through the in-game sales of virtual currency and through advertising. The company has one operating segment with one business activity, developing and monetizing social games.